Epinephrine (Epinephrine)

Trade Name : Epinephrine

Teva Pharmaceuticals USA, Inc.

INJECTION

Strength 0.15 mg/.3mL

EPINEPHRINE Adrenergic alpha-Agonists [MoA],Adrenergic beta-Agonists [MoA],alpha-Adrenergic Agonist [EPC],beta-Adrenergic Agonist [EPC],Catecholamine [EPC],Catecholamines [CS]

Delivery Process

Submit a Request

You can fill in a request for your medicine through the form provided. You can access the form by clicking on the ‘Get Price’ button.

We’ll Get in Touch

Once we review your request, we’ll send you an estimated price for the medicine within 2-5 days.

Confirmation and Payment

You can fill in a request for your medicine through the form provided. You can access the form by clicking on the ‘Get Price’ button.

Submit a Request

You can fill in a request for your medicine through the form provided. You can access the form by clicking on the ‘Get Price’ button.

Product information is meant for

Wholesalers Suppliers Exporters Doctors MOH Tender Supplies Hospitals Brand CROs Comparator Supplies Generic Cooperate Sourcing Individual Patients Indian Institutional Buyers

Disclaimer

Trade Marks displayed in compliance with provisions of: Trademark Act, 1999 u/s 30 and 30 (1) of "Fair use"

GNH India is WHO GDP and ISO 9001 2015 Certified Pharmaceutical Wholesaler/ Supplier/ Exporters/ Importer from India of Epinephrine (Epinephrine) which is also known as Epinephrine and Manufactured by Teva Pharmaceuticals USA, Inc.. It is available in strength of 0.15 mg/.3mL per ml. Read more

Epinephrine (Epinephrine) is supplied for Tenders/ Emergency imports/ Un - licensed, Specials, Orphan drug/ Name patient line/ RLD supplies/ Reference listed drugs/ Comparator Drug/ Bio-Similar/ Innovator samples For Clinical trials. Click to know price. Read less

Packaging and Delivery

Validated Cold Chain Shipment

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

Inquire directly from our website and get 5% off on any medicine!

About GNH

No data

Epinephrine Injection, 0.3 mg and Epinephrine Injection, 0.15 mg are indicated in the emergency treatment of allergic reactions (Type I) including anaphylaxis to stinging insects (e.g., order Hymenoptera, which include bees, wasps, hornets, yellow jackets and fire ants) and biting insects (e.g., triatoma, mosquitoes), allergen immunotherapy, foods, drugs, diagnostic testing substances (e.g., radiocontrast media) and other allergens, as well as idiopathic anaphylaxis or exercise-induced anaphylaxis.
Epinephrine Injection, 0.3 mg and Epinephrine Injection, 0.15 mg are intended for immediate administration in patients who are determined to be at increased risk for anaphylaxis, including individuals with a history of anaphylactic reactions.
Anaphylactic reactions may occur within minutes after exposure and consist of flushing, apprehension, syncope, tachycardia, thready or unobtainable pulse associated with a fall in blood pressure, convulsions, vomiting, diarrhea and abdominal cramps, involuntary voiding, wheezing, dyspnea due to laryngeal spasm, pruritus, rashes, urticaria or angioedema.
Epinephrine Injection, 0.3 mg and Epinephrine Injection, 0.15 mg are intended for immediate administration as emergency supportive therapy only and are not a substitute for immediate medical care.
Epinephrine Injection, 0.3 mg and Epinephrine Injection, 0.15 mg contain epinephrine, a non-selective alpha and beta-adrenergic receptor agonist, indicated in the emergency treatment of allergic reactions (Type I) including anaphylaxis. ()

Selection of the appropriate dosage strength (epinephrine injection, 0.3 mg or epinephrine injection, 0.15 mg) is determined according to patient body weight.
Inject epinephrine injection, 0.3 mg or epinephrine injection, 0.15 mg intramuscularly or subcutaneously into the anterolateral aspect of the thigh, through clothing if necessary. Instruct caregivers of young children who are prescribed an epinephrine injection, 0.3 mg or epinephrine injection, 0.15 mg and who may be uncooperative and kick or move during an injection to hold the leg firmly in place and limit movement prior to and during an injection [].
Each epinephrine injection, 0.3 mg or epinephrine injection, 0.15 mg contains a single dose of epinephrine for single-use injection. Since the doses of epinephrine delivered from epinephrine injection, 0.3 mg or epinephrine injection, 0.15 mg are fixed, consider using other forms of injectable epinephrine if doses lower than 0.15 mg are deemed necessary.
The prescriber should carefully assess each patient to determine the most appropriate dose of epinephrine, recognizing the life-threatening nature of the reactions for which this drug is indicated. With severe persistent anaphylaxis, repeat injections with an additional epinephrine injection, 0.3 mg or epinephrine injection, 0.15 mg may be necessary. More than two sequential doses of epinephrine should only be administered under direct medical supervision [].
The epinephrine solution in the clear window of the epinephrine (auto-injector) should be inspected visually for particulate matter and discoloration. Epinephrine is light sensitive and the (auto-injector) is manufactured from transparent UV stabilized polycarbonate [].
Inject Epinephrine Injection, 0.3 mg and Epinephrine Injection, 0.15 mg intramuscularly or subcutaneously into the anterolateral aspect of the thigh, through clothing if necessary. Each device is a single-use injection. ()

Patients greater than or equal to 30 kg (66 lbs): Epinephrine injection, 0.3 mg ()
Patients 15 to 30 kg (33 lbs to 66 lbs): Epinephrine injection, 0.15 mg ()

Epinephrine: Injection, 0.3 mg/0.3 mL epinephrine injection USP, pre-filled auto-injector
Epinephrine: Injection, 0.15 mg/0.3 mL epinephrine injection USP, pre-filled auto-injector

Epinephrine: Injection, 0.3 mg: 0.3 mg/0.3 mL epinephrine, USP, pre-filled auto-injector ()
Epinephrine: Injection, 0.15 mg: 0.15 mg/0.3 mL epinephrine, USP, pre-filled auto-injector ()

None
None ()

No data

In conjunction with use, seek immediate medical or hospital care. ()
Do not inject intravenously, into buttock, or into digits, hands, or feet. ()
To minimize the risk of injection related injury, instruct caregivers to hold the childu2019s leg firmly in place and limit movement prior to and during injection when administering to young children. (n
Rare cases of serious skin and soft tissue infections have been reported following epinephrine injection. Advise patients to seek medical care if they develop signs or symptoms of infection. ()
The presence of a sulfite in this product should not deter use. ()
Administer with caution in patients with heart disease; may aggravate angina pectoris or produce ventricular arrhythmias. ()

Due to the lack of randomized, controlled clinical trials of epinephrine for the treatment of anaphylaxis, the true incidence of adverse reactions associated with the systemic use of epinephrine is difficult to determine. Adverse reactions reported in observational trials, case reports, and studies are listed below.
Common adverse reactions to systemically administered epinephrine include anxiety; apprehensiveness; restlessness; tremor; weakness; dizziness; sweating; palpitations; pallor; nausea and vomiting; headache; and/or respiratory difficulties. These symptoms occur in some persons receiving therapeutic doses of epinephrine, but are more likely to occur in patients with hypertension or hyperthyroidism [n n ].
Arrhythmias, including fatal ventricular fibrillation, have been reported, particularly in patients with underlying cardiac disease or those receiving certain drugs [ and n ].
Rapid rises in blood pressure have produced cerebral hemorrhage, particularly in elderly patients with cardiovascular disease [n ].
Angina may occur in patients with coronary artery disease [].
Rare cases of stress cardiomyopathy have been reported in patients treated with epinephrine.
Accidental injection into the digits, hands or feet may result in loss of blood flow to the affected area [n ].
Adverse events experienced as a result of accidental injections may include increased heart rate, local reactions including injection site pallor, coldness and hypoesthesia or injury at the injection site resulting in bruising, bleeding, discoloration, erythema or skeletal injury.
Lacerations, bent needles, and embedded needles have been reported when epinephrine injection has been injected into the thigh of young children who are uncooperative and kick or move during the injection [n ].
Injection into the buttock has resulted in cases of gas gangrene [n ].
Rare cases of serious skin and soft tissue infections, including necrotizing fasciitis and myonecrosis caused by Clostridia (gas gangrene), have been reported following epinephrine injection, including epinephrine injection 0.3 mg, in the thigh [].
Adverse reactions to epinephrine include anxiety, apprehensiveness, restlessness, tremor, weakness, dizziness, sweating, palpitations, pallor, nausea and vomiting, headache, and/or respiratory difficulties. ()
To report SUSPECTED ADVERSE REACTIONS, contact Teva Pharmaceuticals USA, Inc. at 1-888-838-2872 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Patients who receive epinephrine while concomitantly taking cardiac glycosides, diuretics, or anti-arrhythmics should be observed carefully for the development of cardiac arrhythmias [].
The effects of epinephrine may be potentiated by tricyclic antidepressants, monoamine oxidase inhibitors, levothyroxine sodium, and certain antihistamines, notably chlorpheniramine, tripelennamine, and diphenhydramine.
The cardiostimulating and bronchodilating effects of epinephrine are antagonized by beta-adrenergic blocking drugs, such as propranolol.
The vasoconstricting and hypertensive effects of epinephrine are antagonized by alpha-adrenergic blocking drugs, such as phentolamine.
Ergot alkaloids may also reverse the pressor effects of epinephrine.

Cardiac glycosides or diuretics: observe for development of cardiac arrhythmias. ()
Tricyclic antidepressants, monoamine oxidase inhibitors, levothyroxine sodium, and certain antihistamines: potentiate effects of epinephrine. ()
Beta-adrenergic blocking drugs: antagonize cardiostimulating and bronchodilating effects of epinephrine. ()
Alpha-adrenergic blocking drugs: antagonize vasoconstricting and hypertensive effects of epinephrine. ()
Ergot alkaloids: may reverse the pressor effects of epinephrine. ()

No data

Elderly patients may be at greater risk of developing adverse reactions. (, 8.5)

Overdosage of epinephrine may produce extremely elevated arterial pressure, which may result in cerebrovascular hemorrhage, particularly in elderly patients. Overdosage may also result in pulmonary edema because of peripheral vascular constriction together with cardiac stimulation. Treatment consists of rapidly acting vasodilators or alpha-adrenergic blocking drugs and/or respiratory support.
Epinephrine overdosage can also cause transient bradycardia followed by tachycardia, and these may be accompanied by potentially fatal cardiac arrhythmias. Premature ventricular contractions may appear within one minute after injection and may be followed by multifocal ventricular tachycardia (prefibrillation rhythm). Subsidence of the ventricular effects may be followed by atrial tachycardia and occasionally by atrioventricular block. Treatment of arrhythmias consists of administration of a beta-adrenergic blocking drug such as propranolol.
Overdosage sometimes results in extreme pallor and coldness of the skin, metabolic acidosis, and kidney failure. Suitable corrective measures must be taken in such situations.

Epinephrine Injection USP, 0.3 mg and Epinephrine Injection USP, 0.15 mg are auto-injectors and combination products containing drug and device components.
Each Epinephrine Injection USP, 0.3 mg (Auto-Injector) delivers a single dose of 0.3 mg epinephrine, USP from epinephrine injection USP 0.3 mg/0.3 mL in a sterile solution.
Each Epinephrine Injection USP, 0.15 mg (Auto-Injector) delivers a single dose of 0.15 mg epinephrine, USP from epinephrine injection USP 0.15 mg/0.3 mL in a sterile solution.
The Epinephrine Injection USP, 0.3 mg and Epinephrine Injection USP, 0.15 mg (Auto-Injectors) each contain 1 mL epinephrine, USP solution. Approximately 0.7 mL remains in the auto-injector after activation, but is not available for future use, and should be discarded.
Each 0.3 mL in the Epinephrine Injection USP, 0.3 mg (Auto-Injector) contains 0.3 mg epinephrine, USP, 1.8 mg sodium chloride, 0.4 mg sodium metabisulfite, 0.4 mg sodium tartrate (dihydrate), hydrochloric acid to adjust pH, and water for injection. The pH range is 2.2 to 5.0.
Each 0.3 mL in the Epinephrine Injection USP, 0.15 mg (Auto-Injector) contains 0.15 mg epinephrine, USP, 1.8 mg sodium chloride, 0.4 mg sodium metabisulfite, 0.2 mg sodium tartrate (dihydrate), hydrochloric acid to adjust pH, and water for injection. The pH range is 2.2 to 5.0.
Epinephrine, USP is a sympathomimetic catecholamine. Chemically, epinephrine, USP is (-)-3,4-Dihydroxy-u03b1-[(methylamino)methyl]benzyl alcohol with the following structure:
Epinephrine, USP solution deteriorates rapidly on exposure to air or light, turning pink from oxidation to adrenochrome and brown from the formation of melanin. Replace Epinephrine Injection USP, 0.3 mg and Epinephrine Injection USP, 0.15 mg if the epinephrine, USP solution appears discolored (pinkish or darker than slightly yellow) or if it contains a precipitate.
Thoroughly review the patient instructions and operation of Epinephrine Injection USP, 0.3 mg or Epinephrine Injection USP, 0.15 mg with patients and caregivers prior to use [n ].

No data

Long-term studies to evaluate the carcinogenic potential of epinephrine have not been conducted.
Epinephrine and other catecholamines have been shown to have mutagenic potential . Epinephrine was positive in the bacterial reverse mutation assay, positive in the mouse lymphoma assay, and negative in the micronucleus assay. Epinephrine is an oxidative mutagen based on the WP2 Mutoxitest bacterial reverse mutation assay. This should not prevent the use of epinephrine under the conditions noted under .
The potential for epinephrine to impair reproductive performance has not been evaluated, but epinephrine has been shown to decrease implantation in female rabbits dosed subcutaneously with 1.2 mg/kg/day (40-fold the highest human intramuscular or subcutaneous daily dose) during gestation days 3 to 9.

No data

[]
A healthcare provider should review the patient instructions and operation of epinephrine injection, 0.3 mg and epinephrine injection, 0.15 mg in detail, with the patient or caregiver.
Epinephrine is essential for the treatment of anaphylaxis. Patients who are at risk of or with a history of severe allergic reactions (anaphylaxis) to insect stings or bites, foods, drugs, and other allergens, as well as idiopathic and exercise-induced anaphylaxis, should be carefully instructed about the circumstances under which epinephrine should be used.
Administration and Training
Instruct patients and/or caregivers in the appropriate use of epinephrine injection, 0.3 mg and epinephrine injection, 0.15 mg. Epinephrine injection, 0.3 mg and epinephrine injection, 0.15 mg should be injected into the middle of the outer thigh (through clothing, if necessary). Each device is a single-use injection. Advise patients to seek immediate medical care in conjunction with administration of epinephrine injection, 0.3 mg and epinephrine injection, 0.15 mg.
Instruct caregivers to hold the leg of young children firmly in place and limit movement prior to and during injection. Lacerations, bent needles, and embedded needles have been reported when epinephrine injection, 0.3 mg and epinephrine injection, 0.15 mg have been injected into the thigh of young children who are uncooperative and kick or move during an injection [].
Complete patient information, including dosage, directions for proper administration and precautions can be found inside each epinephrine injection, 0.3 mg or epinephrine injection, 0.15 mg carton. A printed label on the surface of epinephrine injection, 0.3 mg and epinephrine injection, 0.15 mg shows instructions for use and a diagram depicting the injection process.
Instruct patients and/or caregivers to use and practice with the Trainer to familiarize themselves with the use of epinephrine injection, 0.3 mg and epinephrine injection, 0.15 mg in an allergic emergency. The Trainer may be used multiple times. A Trainer device is provided in 2-Pack cartons.
Adverse Reactions
Epinephrine may produce symptoms and signs that include an increase in heart rate, the sensation of a more forceful heartbeat, palpitations, sweating, nausea and vomiting, difficulty breathing, pallor, dizziness, weakness or shakiness, headache, apprehension, nervousness, or anxiety. These signs and symptoms usually subside rapidly, especially with rest, quiet and recumbency. Patients with hypertension or hyperthyroidism may develop more severe or persistent effects, and patients with coronary artery disease could experience angina. Patients with diabetes may develop increased blood glucose levels following epinephrine administration. Patients with Parkinsonu2019s disease may notice a temporary worsening of symptoms [].
Accidental Injection
Advise patients to seek immediate medical care in the case of accidental injection. Since epinephrine is a strong vasoconstrictor when injected into the digits, hands, or feet, treatment should be directed at vasodilatation if there is such an accidental injection to these areas [].
Serious Infections at the Injection Site
Rare cases of serious skin and soft tissue infections, including necrotizing fasciitis and myonecrosis caused by Clostridia (gas gangrene), have been reported at the injection site following epinephrine injection for anaphylaxis. Advise patients to seek medical care if they develop signs or symptoms of infection, such as persistent redness, warmth, swelling, or tenderness, at the epinephrine injection site [].
Storage and Handling
Instruct patients to inspect the epinephrine solution visually through the clear window of the auto-injector periodically. Replace epinephrine injection, 0.3 mg and epinephrine injection, 0.15 mg if the epinephrine solution appears discolored (pinkish or darker than slightly yellow) or if it contains a precipitate. Epinephrine is light sensitive and should be protected from light. The auto-injector is not waterproof. Instruct patients that epinephrine injection, 0.3 mg and epinephrine injection, 0.15 mg must be used or properly disposed once the blue safety release is removed or after use [].
Complete patient information, including dosage, directions for proper administration and precautions can be found inside each epinephrine injection, 0.3 mg (Auto-Injector) and epinephrine injection, 0.15 mg (Auto-Injector) carton.
Manufactured For:n North Wales, PA 19454
Rev. A 9/2018

Epinephrine Injection USP, 0.3 mg (Auto-Injector)
Epinephrine Injection USP, 0.3 mg = one dose of 0.3 mg epinephrine USP, 0.3 mg/0.3 mL
Epinephrine Injection USP, 0.15 mg (Auto-Injector)
Epinephrine Injection USP, 0.15 mg = one dose of 0.15 mg epinephrine USP, 0.15 mg/0.3 mL
For allergic emergencies (anaphylaxis)
Patient Information
Read this Patient Information Leaflet carefully before using the epinephrine injection, 0.3 mg (auto-injector) or epinephrine injection, 0.15 mg (auto-injector) and each time you get a refill. There may be new information. You, your parent, caregiver, or others who may be in a position to administer epinephrine injection, 0.3 mg (auto-injector) or epinephrine injection, 0.15 mg (auto-injector) should know how to use it before you have an allergic emergency.
This information does not take the place of talking with your healthcare provider about your medical condition or your treatment.
What is the most important information I should know about epinephrine injection, 0.3 mg and epinephrine injection, 0.15 mg?
1. Epinephrine injection, 0.3 mg and epinephrine injection, 0.15 mg contain a medicine used to treat allergic emergencies (anaphylaxis). Anaphylaxis can be life threatening, can happen within minutes, and can be caused by stinging and biting insects, allergy injections, foods, medicines, exercise, or unknown causes.Symptoms of anaphylaxis may include:
What are epinephrine injection, 0.3 mg and epinephrine injection, 0.15 mg?
What should I tell my healthcare provider before using the epinephrine injection, 0.3 mg or epinephrine injection, 0.15 mg?
Before you use epinephrine injection, 0.3 mg or epinephrine injection, 0.15 mg, tell your healthcare provider about all your medical conditions, but especially if you:
Tell your healthcare provider about all the medicines you take
Especially tell your healthcare provider if you take certain asthma medicines.
Epinephrine injection, 0.3 mg or epinephrine injection, 0.15 mg and other medicines may affect each other, causing side effects. Epinephrine injection, 0.3 mg or epinephrine injection, 0.15 mg may affect the way other medicines work, and other medicines may affect how epinephrine injection, 0.3 mg or epinephrine injection, 0.15 mg work.
Know the medicines you take. Keep a list of them to show your healthcare provider and pharmacist when you get a new medicine.
Use your epinephrine injection, 0.3 mg or epinephrine injection, 0.15 mg for treatment of anaphylaxis as prescribed by your healthcare provider, regardless of your medical conditions or the medicines you take.
How should I use epinephrine injection, 0.3 mg and epinephrine injection, 0.15 mg?
What are the possible side effects of epinephrine injection, 0.3 mg and epinephrine injection, 0.15 mg?
Epinephrine injection, 0.3 mg and epinephrine injection, 0.15 mg may cause serious side effects.
Common side effects of epinephrine injection, 0.3 mg and epinephrine injection, 0.15 mg include:
These side effects may go away with rest.u00a0n
These are not all the possible side effects of the epinephrine injection, 0.3 mg or epinephrine injection, 0.15 mg. For more information, ask your healthcare provider or pharmacist.
Call your healthcare provider for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
How should I store epinephrine injection, 0.3 mg and epinephrine injection, 0.15 mg?
Keep epinephrine injection, 0.3 mg and epinephrine injection, 0.15 mg and all medicines out of the reach of children.
General information about the safe and effective use of epinephrine injection, 0.3 mg and epinephrine injection, 0.15 mg
Medicines are sometimes prescribed for purposes other than those listed in a Patient Information Leaflet. Do not use the epinephrine injection, 0.3 mg or epinephrine injection, 0.15 mg for a condition for which it was not prescribed. Do not give your epinephrine injection, 0.3 mg or epinephrine injection, 0.15 mg to other people.
This Patient Information Leaflet summarizes the most important information about epinephrine injection, 0.3 mg and epinephrine injection, 0.15 mg. If you would like more information, talk to your healthcare provider. You can ask your pharmacist or healthcare provider for information about epinephrine injection, 0.3 mg and epinephrine injection, 0.15 mg that is written for health professionals.
For more information and video instructions on the use of epinephrine injection, 0.3 mg and epinephrine injection, 0.15 mg go to www.TevaEpinephrine.com or call 1-888-838-2872.
What are the ingredients in epinephrine injection, 0.3 mg and epinephrine injection, 0.15 mg?
Active Ingredients
Inactive Ingredients:
Important Information
Instructions for Use
Epinephrine Injection USP, 0.3 mg (Auto-Injector)
Epinephrine Injection USP, 0.3 mg = one dose of 0.3 mg epinephrine USP, 0.3 mg/0.3 mL
Epinephrine Injection USP, 0.15 mg (Auto-Injector)
Epinephrine Injection USP, 0.15 mg = one dose of 0.15 mg epinephrine USP, n
For allergic emergencies (anaphylaxis)
Read these Instructions for Use carefully before you use epinephrine injection, 0.3 mg or epinephrine injection, 0.15 mg. Before you need to use your epinephrine injection, 0.3 mg or epinephrine injection, 0.15 mg, make sure your healthcare provider shows you the right way to use it. Parents, caregivers, and others who may be in a position to administer epinephrine injection, 0.3 mg (auto-injector) or epinephrine injection, 0.15 mg (auto-injector) should also understand how to use it as well. If you have any questions, ask your healthcare provider.
Your Epinephrine Injection, 0.3 mg (Auto-Injector) and Epinephrine Injection, 0.15 mg (Auto-Injector)
Arrayn- Array
A dose of epinephrine injection, 0.3 mg or epinephrine injection, 0.15 mg requires 3 simple steps: Prepare, Administer and Get emergency medical help
Step 1. Prepare epinephrine injection, 0.3 mg or epinephrine injection, 0.15 mg for injection
Note:
Step 2. Administer epinephrine injection, 0.3 mg or epinephrine injection, 0.15 mg
If you are administering epinephrine injection, 0.3 mg or epinephrine injection, 0.15 mg to a young child, hold the leg firmly in place while administering an injection.
Step 3. Get emergency medical help now. You may need further medical attention. You may need to use a second epinephrine injection, 0.3 mg auto-injector or epinephrine injection, 0.15 mg auto-injector if symptoms continue or recur.
Note:
This Patient Information and Instructions for Use has been approved by the U.S. Food and Drug Administration.
KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN.
Manufactured For:
Teva Pharmaceuticals USA, Inc.
North Wales, PA 19454
Iss. 6/2018
Epinephrine Injection USP, 0.3 mg (Auto-Injector)
Epinephrine Injection USP, 0.3 mg = one dose of 0.3 mg epinephrine USP, 0.3 mg/0.3 mL
Epinephrine Injection USP, 0.15 mg (Auto-Injector)
Epinephrine Injection USP, 0.15 mg = one dose of 0.15 mg epinephrine USP, 0.15 mg/0.3 mL
TevaEpinephrine.com
Register your Epinephrine Injection 0.3 mg Auto-Injector or Epinephrine Injection 0.15 mg Auto-Injector atu00a0u00a0and find out more about:
Register up to 6 Epinephrine Injection 0.3 mg Auto-Injectors or Epinephrine Injection 0.15 mg Auto-Injectors and receive automaticu00a0n
For more information about Epinephrine Injection 0.3 mg Auto-Injector or Epinephrine Injection 0.15 mg Auto-Injector and proper use of the products, call Teva at 1-888-838-2872 or visitu00a0.
Epinephrine Injection Trainer Instructions for Use
In an emergency: Do not use the grey Trainer. Use your real yellow Epinephrine Injection 0.3 mg Auto-Injector or green Epinephrine Injection 0.15 mg Auto-Injector.
Important Information
The Epinephrine Injection Trainer
Familiarize yourself with this grey Trainer. Practice until you are comfortable using it.
Your grey colored Trainer:n
u2022u00a0
u2022 The Orange Tip is where the needle comes out of your epinephrine injection 0.3 mg auto-injector or epinephrine injection 0.15 mg auto-injector.
NOTE: With the real yellow Epinephrine Injection 0.3 mg Auto-Injector or green Epinephrine Injection 0.15 mg Auto-Injector, the orange tip covers the needle after self-injection to help protect you from accidentally sticking yourself or others.
In case of an allergic emergency, use the real yellow Epinephrine Injection 0.3 mg Auto-Injector or green Epinephrine Injection 0.15 mg Auto-Injector and not the grey Trainer.
Follow instructions above. Repeat as often as needed until you are able to self-inject quickly and correctly.
Reread:
Train others who could help you in an emergency:
u2022 Your parents, caregivers, and others who may be in a position to administer epinephrine injection 0.3 mg or epinephrine injection 0.15 mg should know howu00a0 u00a0to help you during an allergic emergency (anaphylaxis). Before an emergency occurs, have them:
For more information about the Epinephrine Injection 0.3 mg Auto-Injector and Epinephrine Injection 0.15 mg Auto-Injector and the proper use of the products, go tou00a0.
Caution:
Important differences between the Trainer and your real yellow Epinephrine Injection 0.3 mg (Auto-Injector) or green Epinephrine Injection 0.15 mg (Auto-Injector)
This Trainer Instructions for Use has been approved by the U.S. Food and Drug Administration.
KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN.
Manufactured For:
Teva Pharmaceuticals USA, Inc.
North Wales, PA 19454
Rev. A 7/2019

NDC 0093-5986-27
2-Pack
Epinephrine Injection USP, 0.3 mg (Auto-Injectors)For Allergic Emergencies (Anaphylaxis)
Each carton contains:Two yellow Epinephrine Injection USP, 0.3 mg(Auto-Injectors)
One grey Trainern n
Rx only
2 Auto-Injectors and 1 Trainer
TEVA

NDC 0093-5985-27
2-Pack
Epinephrine Injection USP, 0.15 mg (Auto-Injectors)For Allergic Emergencies (Anaphylaxis)
Each carton contains:
Two green Epinephrine Injection USP, 0.15 mg(Auto-Injectors)
One grey Trainern n
Rx only
2 Auto-Injectors and 1 Trainer
TEVA

Browse Our Services And Processes

Comparator Sourcing for Clinical Trials

GNH India brings over 10 years of experience in Comparator

Name Patient Supply

Today, the exact cause for many rare diseases remains unknown

Validated Cold Chain Shipment

With shifting of pharma industry from synthetic molecules to biologic

Clinical Trials Supply

STOP SOURCING..... START SMART SOURCING...... COME STRAIGHT TO THE SOURCE

Dossiers and Stability Studies

STABILITY STUDIES STABILITY, BA / BE STUDIES Due to our active

Pharmaceutical Contract Manufacturing

GNH Provides Contract Manufacturing services for: Generic Medicines with following

Pricing

PRICING POLICY Terms of sales are typically prepaid, unless otherwise

Disclaimer

Please see the Legal Notice for detailed terms and disclaimers. The Legal Notice governs the use of this Website and by accessing and using this Website you agree to be bound by and accept the Legal Notice.

Browse from other international pharmaceuticals

General

64020 Products

GNH India Brings to over 64036 Product SKUs from India all at 1 place with easy access and global deliveries.

US NDC

71247 Products

GNH India Brings to over 71252 Product SKUs from India all at 1 place with easy access and global deliveries.

Canadian DIN

51046 Products

GNH India Brings to over 51047 Product SKUs from India all at 1 place with easy access and global deliveries.

Swiss Drugs

150 Products

GNH India Brings to over 150 Product SKUs from India all at 1 place with easy access and global deliveries.

NZ Drugs

13296 Products

GNH Brings to over 13298 Product SKUs from India all at 1 place with easy access and global deliveries.

FAQ

Check out our delivery process

Can’t find what
you’re looking for?

Get Price

Epinephrine (Epinephrine)

Trade Name : Epinephrine

INJECTION

Delivery Process

Product information is meant for

Disclaimer

Trade Marks displayed in compliance with provisions of: Trademark Act, 1999 u/s 30 and 30 (1) of "Fair use"

Packaging and Delivery

About GNH

Similar Products

Desogestrel And Ethinyl Estradiol (Emoquette)

Diphenoxylate Hydrochloride And Atropine Sulfate (Diphenoxylate Hydrochloride And Atropine Sulfate)

Fluoxetine Hydrochloride (Fluoxetine)

Metoprolol Succinate (Metoprolol Succinate)

Losartan Potassium (Losartan Potassium)

Browse Our Services And Processes

Disclaimer

Browse from other international pharmaceuticals

General

US NDC

Canadian DIN

Swiss Drugs

NZ Drugs

FAQ

Can’t find what
you’re looking for?

COMPANY

SERVICES

QUICK LINKS

CONTACT US

Epinephrine (Epinephrine)

Trade Name : Epinephrine

INJECTION

Delivery Process

Product information is meant for

Disclaimer

Trade Marks displayed in compliance with provisions of: Trademark Act, 1999 u/s 30 and 30 (1) of "Fair use"

Packaging and Delivery

About GNH

Similar Products

Desogestrel And Ethinyl Estradiol (Emoquette)

Diphenoxylate Hydrochloride And Atropine Sulfate (Diphenoxylate Hydrochloride And Atropine Sulfate)

Fluoxetine Hydrochloride (Fluoxetine)

Metoprolol Succinate (Metoprolol Succinate)

Losartan Potassium (Losartan Potassium)

Browse Our Services And Processes

Disclaimer

Browse from other international pharmaceuticals

General

US NDC

Canadian DIN

Swiss Drugs

NZ Drugs

FAQ

Can’t find what you’re looking for?

COMPANY

SERVICES

QUICK LINKS

CONTACT US

Can’t find what
you’re looking for?